trending Market Intelligence /marketintelligence/en/news-insights/trending/CsfsllQnD6XtaUKhFenbCw2 content esgSubNav
In This List

Oxford Immunotec starts offering for ordinary shares

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Oxford Immunotec starts offering for ordinary shares

Oxford Immunotec Global PLC will sell 2.5 million ordinary shares in an underwritten public offering.

The company has granted the underwriter an option to buy up to 375,000 additional shares.

Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.

BTIG LLC is acting as sole underwriter for the offering.